Episode 47: A disastrous decision from the FDA

from Frazis Capital Podcast · host Michael Frazis

Michael Frazis attempts to understand the FDA's decision to approve Biogen's aducanumab for Alzheimer's and the possible ramifications. 

Episode metadata supplied by the publisher feed · Published Jun 10, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 47: A disastrous decision from the FDA

0:00 13:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 13 minutes long.

This episode was published on June 10, 2021.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!